Inclusion of PROs in clinical trials and clinical practice for individual decision-making and service evaluation.
Development and evaluation of quality of life and other PRO measures, including symptom indices and cancer-specific modules.
Development of decision support resources to support patients to make properly informed, values-based treatment decisions.